PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development News - 4th November 2019
PhoreMost named ‘Biotech Company of the Year’ at Cambridge Independent Science and Technology Awards 2019 News - 31st October 2019
PhoreMost and C4X Discovery announce neurodegeneration focused drug discovery collaboration News - 25th June 2019
PhoreMost and Ligand Subsidiary Vernalis Limited Announce Drug Discovery Collaboration for Novel Oncology Target News - 12th June 2019